Science

Oxford Covid-19 vaccine triggers immune responses in elderly: Report

Prashasti Awasthi Mumbai | Updated on October 26, 2020 Published on October 26, 2020

The Oxford vaccine is being developed in collaboration with AstraZeneca   -  THE HINDU

Since carlier studies had said old people were most vulnerable to coronavirus, health administration needs to be cautioned that positive immunogenicity tests don’t mean vaccine is safe, effective for old people, says report

The Oxford coronavirus vaccine candidate produced robust immune responses in elderly people, says a report by the Financial Times.

The exclusive report released on Monday stated that the vaccine prompts protective antibodies and T-cells in old people.

Earlier studies had stated that old people are most vulnerable to the coronavirus and are at risk of developing severe symptoms.

The Oxford vaccine is being developed in collaboration with AstraZeneca.

Should we have Covid-19 lockdowns just for the old?

The newspaper cited two sources who were aware of the matter. It noted that the recent development is in line with the data released in July that claimed the vaccine triggered “robust immune responses” in a group of healthy adults aged between 18 and 55.

However, the report added that health administration needs to be cautioned as positive immunogenicity tests do not mean that the vaccine is safe and effective for older people to take.

Are T cells more important than antibodies in fight against coronavirus?

FT added that the details of the findings will soon be published in a clinical journal, without mentioning the name.

Recently, researchers found that age is not the factor that makes people susceptible to coronavirus, severity of the symptoms is, a study published in the journal EurekAlert! revealed.

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on October 26, 2020
This article is closed for comments.
Please Email the Editor